Home » Topics » BioWorld Science

BioWorld Science
RSS

Fully humanized antibody for diagnosis and therapy of cancer

Oct. 10, 2001

Avigen's Coagulin-B gene therapy for hemophilia B trial on clinical hold

Oct. 10, 2001

3-Dimensional Pharmaceuticals to receive milestone payment for thrombin inhibitor program

Oct. 10, 2001

Gene therapy for B-cell malignancies heading for phase II testing

Oct. 10, 2001

Daiichi presents chemistry and pharmacology for diaminobutane AMPA receptor antagonists

Oct. 10, 2001

Positive data presented for OC-1016, a novel bone- and tissue-regenerating agent

Oct. 10, 2001

Karo Bio updates KB-002611 clinical development

Oct. 10, 2001

Platinum complexes simultaneously targeting DNA and thioredoxin reductase

Oct. 10, 2001

Licensing agreement announced for ramoplanin

Oct. 10, 2001

Lorus and Faulding establish Virulizin distribution agreement for Latin America

Oct. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...